VJVaibhao Janbandhu

Vaibhao Janbandhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vaibhao Janbandhu has a total of 105 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Aging activates latent enhancers that can be reversed with exercise

    by Jack Clarke, Fujian Wu, Vaibhao Janbandhu, Samuel Bagot, David Zheng, Pablo Mantilla Puccetti, Delfine Cheng, Xueqian Zhuang, Hoor E Maksura, Xuan Zhang, et al.

    Aging profoundly alters the genome’s regulatory landscape, but the properties of age-acquired enhancers, including how they are selected and sustained in aged animals are unclear. We used single-cell multiomics in the mouse heart to identify age-responsive cis-regulatory elements and endurance exercise to understand which of these elements can be attenuated. Aging increased AP-1 engagement at more than 100,000 regulatory loci across cardiac cell types. Exercise opposed most of these gains. Despite low endogenous accessibility, age-gained enhancer sequences drove reporter activity comparable to stable elements, revealing substantial latent transcriptional potential. Local sequence features distinguished responsiveness to aging and exercise. Reporter perturbations implicated sequence outside the AP-1 core, and mutagenesis localized informative positions to dispersed segments of dynamic enhancers. These enhancers were IL-1β-sensitive and were preferentially responsive to neutralization of the cytokine in vivo. AP-1 inhibition further opposed age-associated transcription. Together, these findings support a model in which aging engages latent cell-type specific enhancers that are sustained in an active state by ongoing trans signaling. Aging therefore changes the deployment of existing regulatory information, while the acquired activity remains responsive to changes in signaling even in old age.

  • Open Access

    Preemptive cardioprotection with a small molecule in rodents that suppresses genes predictive of heart failure

    by Yue Li, Matthew V. Andrews, David T. Humphreys, Eric Lam, Christopher J. O’KEeffe, Michaella N. Albao, Zuhayr Jafri, Mark J. Raftery, Ling Zhong, Connor H. O’MEara, et al.

    Ischemic heart disease is a leading cause of death worldwide. While percutaneous coronary intervention (PCI) restores blood flow in acute coronary syndrome (ACS), reperfusion injury exacerbates myocardial damage, contributing to heart failure (HF). Preemptive administration of a cardioprotective agent could help counter the imminent proinflammatory insult of PCI and reperfusion. Administering BT2, a small-molecule MAPK kinase/extracellular signal–regulated kinase inhibitor, 24 hours before and during ischemia in rats before reperfusion reduced infarct size by ~70% and preserved cardiac function 24 hours and 2 weeks postinjury. BT2 prevented adverse left ventricular remodeling and scarring. Single nucleus RNA sequencing (snRNA-seq) and bulk RNA-seq revealed that BT2 modulated genes associated with inflammation, fibrosis, and matrix production, especially within macrophages and myofibroblasts. BT2 suppressed macrophage and neutrophil infiltration. BT2 reduced the expression of genes in rodent hearts predictive of HF in patients with ACS, including many encoding cytokines, inflammasome components, and damage-associated molecular patterns. BT2 is a small molecule that can prevent myocardial ischemia-reperfusion injury, improve heart function, reduce cardiac fibrosis, and favorably modulate multiple key genes and biological processes in rats prognostic of HF when delivered before reperfusion. This strategy could be evaluated with high-risk unstable angina/non-ST-segment elevation myocardial infarction patients or those having an elective PCI.


  • Open Access

    Loss of conserved long non-coding RNA MIR503HG leads to altered NOTCH pathway signalling and left ventricular non-compaction cardiomyopathy

    by João P Monteiro, Diptarka Saha, Ana-Mishel Spiroski, Saiba Mahesh, Peter Kaltzis, Abhijit Nadavallil, Vaibhao Janbandhu, Nicholas J Murray, Francesco Severi, Azzurra Laura De Pace, et al.

    Aims: The highly conserved long non-coding RNA (lncRNA) MIR505HG has been primarily recognized as a precursor for microRNAs (miR)-424 and miR-503. However, studies have since demonstrated that MIR503HG has distinct functions from its associated miRNAs, playing important roles in cell proliferation, invasion, apoptosis, and differentiation. While these miRNAs are known to influence cardiomyocyte differentiation, the specific role of MIR503HG in heart development remains unexplored. We seek to determine how MIR503HG deletion impacts ventricular chamber development and to identify underlying molecular mechanisms. Methods and results: To study the role of the lncRNA in vivo, we generated a functional MIR503HG knockout mouse model (MIR503HG−/−) using a synthetic polyadenylation signal to terminate MIR503HG transcription without affecting miR-424/503 expression. We performed morphological analyses on embryonic and adult hearts using microCT along with cardiac functional analysis via transthoracic echocardiography. We further apply single-nuclei RNA sequencing (snRNA-seq) on adult hearts to identify potential molecular mechanisms underlying the observed phenotypes. Functional deletion of MIR503HG alone was associated with reduced compact myocardium thickness and increased trabecular myocardium in the left ventricle (LV) at embryonic day 17.5 compared to wild-type mice, indicating a LV non-compaction (LVNC) phenotype. Moreover, adult MIR503HG−/− mutant hearts showed increased trabecular complexity, impaired LV relaxation, and mitral valve regurgitation. SnRNA-seq further revealed altered expression of several genes associated with cardiomyocyte function and LVNC, including Actc1, Mib1, Mybpc3, and Myh7. Lastly, Notch1 activity was also significantly increased in mutant hearts which has been previously associated with LVNC. Conclusion: MIR503HG plays a role in ventricular chamber development, and its deletion leads to an LVNC phenotype independent of the miRNA cluster within its locus, highlighting its importance in cardiac development and disease. We further suggest that abnormal Notch1 activity may underpin the LVNC phenotype presented.


  • Top Cited Papers
    Open Access

    Integration mapping of cardiac fibroblast single-cell transcriptomes elucidates cellular principles of fibrosis in diverse pathologies

    by Ralph Patrick, Vaibhao Janbandhu, Vikram Tallapragada, Shannon S. M. Tan, Emily E. McKinna, Osvaldo Contreras, Shila Ghazanfar, David T. Humphreys, Nicholas J. Murray, Yen T. H. Tran, et al.

    Single-cell technology has allowed researchers to probe tissue complexity and dynamics at unprecedented depth in health and disease. However, the generation of high-dimensionality single-cell atlases and virtual three-dimensional tissues requires integrated reference maps that harmonize disparate experimental designs, analytical pipelines, and taxonomies. Here, we present a comprehensive single-cell transcriptome integration map of cardiac fibrosis, which underpins pathophysiology in most cardiovascular diseases. Our findings reveal similarity between cardiac fibroblast (CF) identities and dynamics in ischemic versus pressure overload models of cardiomyopathy. We also describe timelines for commitment of activated CFs to proliferation and myofibrogenesis, profibrotic and antifibrotic polarization of myofibroblasts and matrifibrocytes, and CF conservation across mouse and human healthy and diseased hearts. These insights have the potential to inform knowledge-based therapies.


  • Novel Mouse Model for Selective Tagging, Purification, and Manipulation of Cardiac Myofibroblasts

    by Vaibhao Janbandhu, Vikram Tallapragada, Jinyuan Vero Li, Bharti Shewale, Shila Ghazanfar, Ralph Patrick, Charles D. Cox, Richard P. Harvey


  • Open Access

    Quantitative trait and transcriptome analysis of genetic complexity underpinning cardiac interatrial septation in mice using an advanced intercross line

    by Mahdi Moradi Marjaneh, Edwin P Kirk, Ralph Patrick, Dimuthu Alankarage, David T Humphreys, Gonzalo Del Monte-Nieto, Paola Cornejo-Paramo, Vaibhao Janbandhu, Tram B Doan, Sally L Dunwoodie, et al.

    Unlike single-gene mutations leading to Mendelian conditions, common human diseases are likely to be emergent phenomena arising from multilayer, multiscale, and highly interconnected interactions. Atrial and ventricular septal defects are the most common forms of cardiac congenital anomalies in humans. Atrial septal defects (ASD) show an open communication between the left and right atria postnatally, potentially resulting in serious hemodynamic consequences if untreated. A milder form of atrial septal defect, patent foramen ovale (PFO), exists in about one-quarter of the human population, strongly associated with ischaemic stroke and migraine. The anatomic liabilities and genetic and molecular basis of atrial septal defects remain unclear. Here, we advance our previous analysis of atrial septal variation through quantitative trait locus (QTL) mapping of an advanced intercross line (AIL) established between the inbred QSi5 and 129T2/SvEms mouse strains, that show extremes of septal phenotypes. Analysis resolved 37 unique septal QTL with high overlap between QTL for distinct septal traits and PFO as a binary trait. Whole genome sequencing of parental strains and filtering identified predicted functional variants, including in known human congenital heart disease genes. Transcriptome analysis of developing septa revealed downregulation of networks involving ribosome, nucleosome, mitochondrial, and extracellular matrix biosynthesis in the 129T2/SvEms strain, potentially reflecting an essential role for growth and cellular maturation in septal development. Analysis of variant architecture across different gene features, including enhancers and promoters, provided evidence for the involvement of non-coding as well as protein-coding variants. Our study provides the first high-resolution picture of genetic complexity and network liability underlying common congenital heart disease, with relevance to human ASD and PFO.


  • Open Access

    Cardiac fibroblast heterogeneity and dynamics through the lens of single-cell dual ‘omics

    by Richard P. Harvey, Ralph Patrick, Vaibhao Janbandhu, Osvaldo Contreras

    This editorial refers to ‘Single-cell dual-omics reveals the transcriptomic and epigenomic diversity of cardiac non-myocytes’ by L.Wang et al., doi: 10.1093/cvr/cvab134.


  • Open Access

    An image analysis protocol using CellProfiler for automated quantification of post-ischemic cardiac parameters

    by Alexander O. Ward, Vaibhao Janbandhu, Gavin Chapman, Sally L. Dunwoodie, Richard P. Harvey


  • Open Access

    Sierra: discovery of differential transcript usage from polyA-captured single-cell RNA-seq data

    by Ralph Patrick, David T. Humphreys, Vaibhao Janbandhu, Alicia Oshlack, Joshua W.K. Ho, Richard P. Harvey, Kitty K. Lo

    High-throughput single-cell RNA-seq (scRNA-seq) is a powerful tool for studying gene expression in single cells. Most current scRNA-seq bioinformatics tools focus on analysing overall expression levels, largely ignoring alternative mRNA isoform expression. We present a computational pipeline, Sierra, that readily detects differential transcript usage from data generated by commonly used polyA-captured scRNA-seq technology. We validate Sierra by comparing cardiac scRNA-seq cell types to bulk RNA-seq of matched populations, finding significant overlap in differential transcripts. Sierra detects differential transcript usage across human peripheral blood mononuclear cells and the Tabula Muris, and 3 ′UTR shortening in cardiac fibroblasts. Sierra is available at https://github.com/VCCRI/Sierra.


  • Top Cited Papers
    Open Access

    Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury

    by Nona Farbehi, Ralph Patrick, Aude Dorison, Munira Xaymardan, Vaibhao Janbandhu, Katharina Wystub-Lis, Joshua Wk Ho, Robert E Nordon, Richard P Harvey

    Besides cardiomyocytes (CM), the heart contains numerous interstitial cell types which play key roles in heart repair, regeneration and disease, including fibroblast, vascular and immune cells. However, a comprehensive understanding of this interactive cell community is lacking. We performed single-cell RNA-sequencing of the total non-CM fraction and enriched (Pdgfra-GFP+) fibroblast lineage cells from murine hearts at days 3 and 7 post-sham or myocardial infarction (MI) surgery. Clustering of >30,000 single cells identified >30 populations representing nine cell lineages, including a previously undescribed fibroblast lineage trajectory present in both sham and MI hearts leading to a uniquely activated cell state defined in part by a strong anti-WNT transcriptome signature. We also uncovered novel myofibroblast subtypes expressing either pro-fibrotic or anti-fibrotic signatures. Our data highlight non-linear dynamics in myeloid and fibroblast lineages after cardiac injury, and provide an entry point for deeper analysis of cardiac homeostasis, inflammation, fibrosis, repair and regeneration.